Mariealane Barbera Hellner, MD
Medical Oncology Physician · Charlotte, NC
Mariealane Barbera Hellner, MD is a medical oncology physician with a practice address in Charlotte, North Carolina, and NPI 1457376469, issued on Jul 12, 2006. Check the license (North Carolina 2005-00916, as entered in NPPES) on the North Carolina Medical Board; the Medicare figures below come from public CMS files.
- Name
- Mariealane Barbera Hellner
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- 2005-00916 NC
Self-reported in NPPES; status is on the state search - Practice location
- 10660 Park RD, Charlotte, NC 28210
- Phone
- (980) 442-0410
- Enumerated
- Jul 12, 2006
- Record last updated
- Jul 15, 2024
- Medicare enrollment
- Enrolled (PECOS I20050913000103); accepts Medicare assignment
- Medical or professional school
- Tulane University School Of Medicine, 1999
- Entity
- Type 1 · individual
Also registered at 10660 Park RD
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Wendy Andres, DPTPhysical Therapist1316178023
- Kulsum Bano, MDHematology & Oncology Physician1114378775
- Earle Burgess, MDHematology (Internal Medicine) Physician1194872044
- Ryan Gleason, MDNeurology Physician1578857975
- Rebecca Henson, PAPhysician Assistant1669005369
- Samantha Henson, PAPhysician Assistant1194212001
Verify Mariealane Barbera Hellner in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNorth Carolina Medical Board
Search for license 2005-00916Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
86% more Medicare Part D claims than the average medical oncology physician in 2024
1,308 Medicare Part D claims for 327 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 6% of claims.
Most prescribed
- Anastrozole689 claims
- Letrozole185 claims
- Tamoxifen Citrate88 claims
- Exemestane52 claims
- Gabapentin42 claims
- Ibrance30 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $880.93
9 payments; by number, the most common kind was long term medical supply or device loan; the largest payer was Novartis Pharmaceuticals Corporation. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- The Charlotte-Mecklenburg Hospital AuthorityCharlotte, NC
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in North Carolina
There are 191 medical oncology physician records in North Carolina.
Other medical oncology physician records in North Carolina
- Amy Abernethy, M.D.Durham, NC1962598094
- Sonia Abuzakhm, MDCharlotte, NC1659571065
- Charles Agbemabiese, M.D.Thomasville, NC1518971852
- Neeraj Agrawal, MDRaleigh, NC1336189174
- Laura AlderDurham, NC1932633617
- Jeffrey Aldrich, MDChapel Hill, NC1629432927
- Asim Amin, MDCharlotte, NC1518965607
- Carey Anders, M.D.Chapel Hill, NC1073786893
- Andrew Armstrong, MDDurham, NC1528160199
- Swetha Arshanapally, M.D.Salisbury, NC1720222094
Common questions
What is Mariealane Barbera Hellner, MD's NPI number?
Mariealane Barbera Hellner, MD's National Provider Identifier (NPI) is 1457376469, issued on Jul 12, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Mariealane Barbera Hellner, MD located?
The NPPES record lists a practice address at 10660 Park RD, Charlotte, NC, 28210. Phone: (980) 442-0410. Providers update this record themselves, so call before visiting.
How can I verify Mariealane Barbera Hellner, MD's license?
NPPES lists North Carolina license number 2005-00916, as entered by the provider. Search the North Carolina Medical Board at https://portal.ncmedboard.org/verification/search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Mariealane Barbera Hellner, MD prescribe under Medicare Part D?
In 2024, Mariealane Barbera Hellner, MD had 1,308 Medicare Part D claims for 327 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Mariealane Barbera Hellner, MD's MIPS final score?
The 2023 MIPS final score is 100 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.